CD44 and glioblastoma: LNP showed a significant targeting effect against GBM cells due to higher expression of CD44, with an increased efficacy of DOX related to the lysosomal evasion, while in healthy cells limited toxicity was observed due to the absence of CD44 active uptake mechanism [40].